Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

NCT04557501 is registered in ClinicalTrials.gov with Centre hospitalier de l'Université de Montréal (CHUM) as lead sponsor.

NCT NCT04557501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04557501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
Lead sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 6, 2021
Completion date
January 31, 2029
Enrollment
800 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer